We Must Protect the Most Vulnerable from COVID

We Must Protect the Most Vulnerable from COVID

On January 12 the U.S. government announced it was purchasing an additional 500,000 doses of AstraZeneca‚Äôs Evusheld, the only pre-exposure treatment approved by the FDA for immune-compromised people who cannot mount a response to the available COVID vaccines. This brings the total U.S. commitment to purchase this vital treatment to 1.2 million doses. While this…